| Dr Gregory Michael Apel, MD | |
|
39000 Bob Hope Dr, Rancho Mirage, CA 92270-3221 | |
| (760) 340-3911 | |
| Not Available |
| Full Name | Dr Gregory Michael Apel |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 12 Years |
| Location | 39000 Bob Hope Dr, Rancho Mirage, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104189620 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 125-060903 (Illinois) | Secondary |
| 207P00000X | Emergency Medicine | 141549 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sharp Coronado Hospital And Hlthcr Ctr | Coronado, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Services Medical Corporation Coronado | 3779904438 | 17 |
| Team Physicians Of Northern California Medical Group Inc | 7113215146 | 95 |
News Archive
The reviews are in, and retirees give the thumbs up to health insurance exchanges. In an independent survey of 443 retirees who use a health insurance exchange to compare and choose private individual Medicare and supplement plans, 85% of their reviews were positive.
Each day, medical devices from renal dialysis machines to implantable defibrillators help prevent, diagnose, treat, and monitor serious and life-threatening diseases. After taking years to develop, these devices then undergo a regulatory review process before entering the marketplace. It then takes even more time for them to be adopted into clinical practice and for patients to realize the benefits.
On Oct. 11, 2011, the FDA approved a labeling supplement for EUFLEXXA (1% sodium hyaluronate) that provides 26-week efficacy data from the FLEXX trial, as well as, 52-week safety data to demonstrate the safety of repeated injection cycles.
ARIAD Pharmaceuticals, Inc. today announced that the Company and collaborating investigators from five major oncology research centers in the United States will present data from a Phase 1 clinical trial of ARIAD's investigational, multi-targeted kinase inhibitor and pan-BCR-ABL inhibitor, AP24534, at the 51st Annual Meeting of the American Society of Hematology (ASH) being held in New Orleans, Louisiana, December 5-8, 2009.
Couples who use fertility awareness-based methods of family planning have sex just as often as couples who use other contraceptive methods - they just time it differently, according to a new Georgetown University Institute for Reproductive Health study to be published in a forthcoming edition of the Journal of Biosocial Science.
› Verified 1 days ago
| Entity Name | Emergency Services Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699725069 PECOS PAC ID: 6204720196 Enrollment ID: O20051215000870 |
News Archive
The reviews are in, and retirees give the thumbs up to health insurance exchanges. In an independent survey of 443 retirees who use a health insurance exchange to compare and choose private individual Medicare and supplement plans, 85% of their reviews were positive.
Each day, medical devices from renal dialysis machines to implantable defibrillators help prevent, diagnose, treat, and monitor serious and life-threatening diseases. After taking years to develop, these devices then undergo a regulatory review process before entering the marketplace. It then takes even more time for them to be adopted into clinical practice and for patients to realize the benefits.
On Oct. 11, 2011, the FDA approved a labeling supplement for EUFLEXXA (1% sodium hyaluronate) that provides 26-week efficacy data from the FLEXX trial, as well as, 52-week safety data to demonstrate the safety of repeated injection cycles.
ARIAD Pharmaceuticals, Inc. today announced that the Company and collaborating investigators from five major oncology research centers in the United States will present data from a Phase 1 clinical trial of ARIAD's investigational, multi-targeted kinase inhibitor and pan-BCR-ABL inhibitor, AP24534, at the 51st Annual Meeting of the American Society of Hematology (ASH) being held in New Orleans, Louisiana, December 5-8, 2009.
Couples who use fertility awareness-based methods of family planning have sex just as often as couples who use other contraceptive methods - they just time it differently, according to a new Georgetown University Institute for Reproductive Health study to be published in a forthcoming edition of the Journal of Biosocial Science.
› Verified 1 days ago
| Entity Name | Team Physicians Of Northern California Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649692716 PECOS PAC ID: 7113215146 Enrollment ID: O20161006002407 |
News Archive
The reviews are in, and retirees give the thumbs up to health insurance exchanges. In an independent survey of 443 retirees who use a health insurance exchange to compare and choose private individual Medicare and supplement plans, 85% of their reviews were positive.
Each day, medical devices from renal dialysis machines to implantable defibrillators help prevent, diagnose, treat, and monitor serious and life-threatening diseases. After taking years to develop, these devices then undergo a regulatory review process before entering the marketplace. It then takes even more time for them to be adopted into clinical practice and for patients to realize the benefits.
On Oct. 11, 2011, the FDA approved a labeling supplement for EUFLEXXA (1% sodium hyaluronate) that provides 26-week efficacy data from the FLEXX trial, as well as, 52-week safety data to demonstrate the safety of repeated injection cycles.
ARIAD Pharmaceuticals, Inc. today announced that the Company and collaborating investigators from five major oncology research centers in the United States will present data from a Phase 1 clinical trial of ARIAD's investigational, multi-targeted kinase inhibitor and pan-BCR-ABL inhibitor, AP24534, at the 51st Annual Meeting of the American Society of Hematology (ASH) being held in New Orleans, Louisiana, December 5-8, 2009.
Couples who use fertility awareness-based methods of family planning have sex just as often as couples who use other contraceptive methods - they just time it differently, according to a new Georgetown University Institute for Reproductive Health study to be published in a forthcoming edition of the Journal of Biosocial Science.
› Verified 1 days ago
| Entity Name | Emergency Services Medical Corporation Coronado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598395675 PECOS PAC ID: 3779904438 Enrollment ID: O20200604001390 |
News Archive
The reviews are in, and retirees give the thumbs up to health insurance exchanges. In an independent survey of 443 retirees who use a health insurance exchange to compare and choose private individual Medicare and supplement plans, 85% of their reviews were positive.
Each day, medical devices from renal dialysis machines to implantable defibrillators help prevent, diagnose, treat, and monitor serious and life-threatening diseases. After taking years to develop, these devices then undergo a regulatory review process before entering the marketplace. It then takes even more time for them to be adopted into clinical practice and for patients to realize the benefits.
On Oct. 11, 2011, the FDA approved a labeling supplement for EUFLEXXA (1% sodium hyaluronate) that provides 26-week efficacy data from the FLEXX trial, as well as, 52-week safety data to demonstrate the safety of repeated injection cycles.
ARIAD Pharmaceuticals, Inc. today announced that the Company and collaborating investigators from five major oncology research centers in the United States will present data from a Phase 1 clinical trial of ARIAD's investigational, multi-targeted kinase inhibitor and pan-BCR-ABL inhibitor, AP24534, at the 51st Annual Meeting of the American Society of Hematology (ASH) being held in New Orleans, Louisiana, December 5-8, 2009.
Couples who use fertility awareness-based methods of family planning have sex just as often as couples who use other contraceptive methods - they just time it differently, according to a new Georgetown University Institute for Reproductive Health study to be published in a forthcoming edition of the Journal of Biosocial Science.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory Michael Apel, MD 39000 Bob Hope Dr, Rancho Mirage, CA 92270-3221 Ph: (760) 340-3911 | Dr Gregory Michael Apel, MD 39000 Bob Hope Dr, Rancho Mirage, CA 92270-3221 Ph: (760) 340-3911 |
News Archive
The reviews are in, and retirees give the thumbs up to health insurance exchanges. In an independent survey of 443 retirees who use a health insurance exchange to compare and choose private individual Medicare and supplement plans, 85% of their reviews were positive.
Each day, medical devices from renal dialysis machines to implantable defibrillators help prevent, diagnose, treat, and monitor serious and life-threatening diseases. After taking years to develop, these devices then undergo a regulatory review process before entering the marketplace. It then takes even more time for them to be adopted into clinical practice and for patients to realize the benefits.
On Oct. 11, 2011, the FDA approved a labeling supplement for EUFLEXXA (1% sodium hyaluronate) that provides 26-week efficacy data from the FLEXX trial, as well as, 52-week safety data to demonstrate the safety of repeated injection cycles.
ARIAD Pharmaceuticals, Inc. today announced that the Company and collaborating investigators from five major oncology research centers in the United States will present data from a Phase 1 clinical trial of ARIAD's investigational, multi-targeted kinase inhibitor and pan-BCR-ABL inhibitor, AP24534, at the 51st Annual Meeting of the American Society of Hematology (ASH) being held in New Orleans, Louisiana, December 5-8, 2009.
Couples who use fertility awareness-based methods of family planning have sex just as often as couples who use other contraceptive methods - they just time it differently, according to a new Georgetown University Institute for Reproductive Health study to be published in a forthcoming edition of the Journal of Biosocial Science.
› Verified 1 days ago
Dr. William D Crecelius, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 72780 Country Club Dr Ste 203, Rancho Mirage, CA 92270 Phone: 760-834-3593 Fax: 760-674-3845 | |
Edward B Cooper, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 39000 Bob Hope Dr, Rancho Mirage, CA 92270 Phone: 760-773-1221 | |
Steven L Stephanides, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 39000 Bob Hope Dr, Uihlein Bldg, 1st Floor, Rancho Mirage, CA 92270 Phone: 330-493-4443 Fax: 330-493-8677 | |
Peter Andersons, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 39000 Bob Hope Dr, Rancho Mirage, CA 92270 Phone: 760-773-1221 | |
Dr. Jeffrey Kile, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 39000 Bob Hope Dr, Rancho Mirage, CA 92270 Phone: 760-773-1221 | |
Francis Domzalski, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 72780 Country Club Dr Ste 203, Rancho Mirage, CA 92270 Phone: 760-834-3593 Fax: 760-674-3845 |